Equity Research, Broker Reports, and media content on AstraZeneca

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about AstraZeneca
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard


Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on AstraZeneca. We currently have 167 research reports from 10 professional analysts.

  • Open: 8430p
  • Range Today: 8430/8505p
  • 52 Week: 6221/9004p
  • Daily Volume: 0.0k
  • Daily Liquidity: (0%)
  • # Shares: 1,312m
  • Market Cap: £111,609m
  • Latest PE (hist): 54.80
  • Div Yield: 3.83
Date Source Announcement
09Jul20 07:00 RNS Brilinta granted US FDA Priority Review for stroke
08Jul20 07:00 RNS Lynparza approved in the EU for pancreatic cancer
01Jul20 15:00 RNS Total Voting Rights
30Jun20 15:00 RNS Director/PDMR Shareholding
30Jun20 07:00 RNS Selumetinib granted Japan orphan drug designation
17Jun20 15:03 RNS Holding(s) in Company
17Jun20 15:00 RNS Holding(s) in Company
  • Frequency of research reports


  • Research reports on


  • Providers covering